innate immune response to Candida
albicans” #BSMM2025 #Norwich2025
innate immune response to Candida
albicans” #BSMM2025 #Norwich2025
Vaccine Prototype (Aspf1-Ad5) for
protection against Aspergillus
fumigatus: A Novel Approach to
Combat Fungal Infections” #BSMM2026 #Norwich2025
Vaccine Prototype (Aspf1-Ad5) for
protection against Aspergillus
fumigatus: A Novel Approach to
Combat Fungal Infections” #BSMM2026 #Norwich2025
action of G-quadruplex-stabilising
ligands in A. fumigatus” one of our local organisers Isabelle Storer #BSMM2025 #Norwich2025
action of G-quadruplex-stabilising
ligands in A. fumigatus” one of our local organisers Isabelle Storer #BSMM2025 #Norwich2025
regulators of fungal infection” he’s also sharing thoughts on his future path as new PI #BSMM2025 #Norwich2025
regulators of fungal infection” he’s also sharing thoughts on his future path as new PI #BSMM2025 #Norwich2025
in Aspergillus fumigatus through an
integrated in vitro and ex vivo
screening platform” #BSMM2025 #Norwich2025
in Aspergillus fumigatus through an
integrated in vitro and ex vivo
screening platform” #BSMM2025 #Norwich2025
neoformans” #BSMM2025 #Norwich2025
neoformans” #BSMM2025 #Norwich2025
heterogeneity and evolution in hyphal networks” #BSMM2025 #Norwich2025
heterogeneity and evolution in hyphal networks” #BSMM2025 #Norwich2025
Ivacaftor therapy in children with
Cystic Fibrosis on allergic
bronchopulmonary aspergillosis
(ABPA) and recovery of Aspergillus
spp. from the airways” #BSMM2025 #Norwich2025
Ivacaftor therapy in children with
Cystic Fibrosis on allergic
bronchopulmonary aspergillosis
(ABPA) and recovery of Aspergillus
spp. from the airways” #BSMM2025 #Norwich2025
of Mucorales” #BSMM2025 #Norwich2025
of Mucorales” #BSMM2025 #Norwich2025
mucormycosis” #BSMM2025 #Norwich2025
mucormycosis” #BSMM2025 #Norwich2025